Most recent update: Tuesday, September 17, 2019 - 16:32

Bariatric News - Cookies & privacy policy

You are here

outcomes

OABG-MGB is an effective option for patients with super-super obesity

One Anastomosis (Mini) Gastric Bypass (OAGB-MGB) is a safe and effective option for management of patients with super obesity (BMI>50kg/m2) and super-super obesity (BMI > 60kg/m2) patients and results in similar or higher %EWL (Excess weight loss) than with other procedures like sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB). Interestingly, they note that the role of tailoring the biliopancreatic limb (BPL) may result in more successful weight loss in the super-obese group, although this requires further research.

Five-year ESG outcomes reveal significant total body weight loss

Endoscopic sleeve gastroplasty (ESG), a relatively new, minimally invasive weight-loss procedure, resulted in significant total body weight loss in the first long-term study to follow patients' progress over five years, according to research - ‘Long-term follow up and outcomes after endoscopic sleeve gastroplasty for treatment of obesity (5-year data)’ (abstract 70) - were presented Digestive Disease Week (DDW) 2019.

Sleeve gastrectomy: A simple operation that is not that simple

Vertical resection of the stomach to reduce the gastric reservoir in the biliopancreatic diversion operation (BPD) was introduced by Hess in order to decrease the incidence of marginal ulcers in that operation and by maintaining the pylorus to also enhance the restrictive effects of the operation and also decrease the incidence of dumping. The volume of the gastric pouch created by Hess was 250-400cc akin to the size of the transverse fundal pouch in the Scopinaro procedure.

RYGB offers better weight loss but higher readmission rates vs LSG

One-year outcomes from over 47,000 Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy procedures has reported that RYGB resulted in a higher rate of patients with total weight loss (TWL) >20% (95.8% vs 84.6%, p<0.001). However, there were no significant differences between the two procedures in the rate of severe complications (2.6% vs 2.4%, p=0.382) and 30-day mortality (0.04% vs 0.03%, p=0.821), although readmission rates were higher post-RYGB (4.3% vs 3.4%, p<0.001).

Endoscopic sleeve gastroplasty well-tolerated, safe and effective in 1,000 patients

Endoscopic sleeve gastroplasty (ESG) appears to be well-tolerated, safe and effective, according to a report from researchers Saudi Arabia, which included 1,000 consecutive patients. The study found that the procedure resulted in significant weight loss occurs during the first 18 months without mortality or significant morbidity, although a minority of patients require revision or reversal during the first year.

Magnetic liver retraction incision-less technique is a safe

Levita Magnetic Surgical System facilitates a safe, reproducible, incision-less technique for port-less intra-abdominal liver retraction during bariatric surgery, according to researchers from Duke University Health System in Durham, NC. The study noted that the device successfully permitted optimal liver retraction during laparoscopic bariatric surgery, facilitating surgical exposure while decreasing the number of abdominal incisions.

Obalon outcomes show 9.9% reduction in total body weight

Clinical data from a large-scale commercial study assessing the safety and efficacy of the Obalon Balloon System, has reported that average weight loss data on patients receiving three balloons and six months of therapy was 21.7lbs, resulting in a 9.9% reduction in total body weight and a 3.5 point decrease in BMI compared to baseline values. The data was presented at the American Society for Metabolic and Bariatric Surgery (ASMBS) Annual Meeting at Obesity Week 2018, by Dr Rachel Moore, bariatric surgeon and weight loss specialist.

Single Anastomosis Duodenum-Ileal anastomosis with SG

The 2nd Gore Expert Obesity Meeting was held at WL Gore and Associates’ Feldkirchen-Westerham location, in Germany, from September 19-20, 2018. The meeting provided surgical specialists from around the world the opportunity to interact, debate and share their experiences with European experts in bariatric and metabolic surgery. Topics under discussion included sleeve gastrectomy, gastric bypass, SADI-S, revisional surgery and staple line reinforcement, as well as how to manage obesity-related condition such as gastroesophageal reflux disease, Hiatal hernia and abdominal wall repairs.

Gelesis100 study: Adults lost on average 10% of their weight

Gelesis, a biotechnology company developing first-in-class mechanotherapeutics to treat obesity and other chronic diseases related to the gastrointestinal (GI) tract, has announced expanded data from its Gelesis Loss of Weight (GLOW) clinical study. GLOW is a pivotal multi-centre, double-blind, placebo-controlled study of the company’s lead investigational candidate, Gelesis100, which is an oral, non-systemic approach to weight loss.

Which procedure is best for children with obesity?

The 23rd World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders was held in Dubai, United Arab Emirates, from September 26-29, 2018. Attended by over 2,500 bariatric specialist and allied healthcare professionals, participants were witness to a superb scientific programme focusing on the widest array of topics in the field of adiposity based chronic diseases, through postgraduate courses, symposia, expert talks and video and pre-recorded operations. Here are some of the highlights from the meeting.

Subscribe to RSS - outcomes